Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/25/2010US20100076070 Forskolin Compositions and Methods For Administration
03/25/2010US20100076069 Forskolin dosing regimen in open angle glaucoma and patient compliance methods thereof
03/25/2010US20100076068 Aminoalcohol Derivatives and Their Therapeutic Use
03/25/2010US20100076067 Biodegradable block copolymeric compositions for drug delivery
03/25/2010US20100076066 Novel IDO Inhibitors and Methods of Use Thereof
03/25/2010US20100076065 Vitamin d receptor modulators
03/25/2010US20100076064 Methods For Improving Liver Clearance of Xenobiotic Substances In An Animal
03/25/2010US20100076063 Genetic modification of targeted regions of the cardiac conduction system
03/25/2010US20100076062 Use of a Truncated eIF-5A1 Polynucleotide to Induce Apoptosis in Cancer Cells
03/25/2010US20100076061 Repeated administration of lentiviral vectors to respiratory cells
03/25/2010US20100076060 Aptamers as agonists
03/25/2010US20100076059 METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10
03/25/2010US20100076058 Methods for identifying analgesic agents
03/25/2010US20100076057 TARGET DNA INTERFERENCE WITH crRNA
03/25/2010US20100076056 MODIFIED iRNA AGENTS
03/25/2010US20100076055 Cationic Lipids and Uses Thereof
03/25/2010US20100076054 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
03/25/2010US20100076053 Sequence of dsrna: atn-rna, intervention using irnai, use of a sequence of dsrna: atn-rna, a method of treating and inhibiting a brain tumor, a kit for inhibiting cancer cell which expresses tenascin, a method for a kit preparation in a brain tumor therapy
03/25/2010US20100076052 Perindopril formulations
03/25/2010US20100076051 Isoindolinone kinase inhibitors
03/25/2010US20100076050 Solid betalain compositions and methods
03/25/2010US20100076049 Novel oxindole derivative
03/25/2010US20100076048 Isoindol Derivatives As EP4 Receptor Agonists
03/25/2010US20100076047 Amorphous 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol phosphate salt
03/25/2010US20100076046 Antiviral Indoles
03/25/2010US20100076045 Stabilized pharmaceutical sub-micron suspensions and methods of forming same
03/25/2010US20100076044 Therapeutic agent for inflammatory bowel disease and tnf-alpha production inhibitor
03/25/2010US20100076043 Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
03/25/2010US20100076042 Pharmaceutical composition
03/25/2010US20100076041 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
03/25/2010US20100076040 Method For Producing Bisbenzoxazoles
03/25/2010US20100076039 Composition for the prevention and treatment of metabolic disorder containing benzazole derivatives as an active ingredient
03/25/2010US20100076038 Therapeutic agent for urinary excretion disorder
03/25/2010US20100076037 Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma
03/25/2010US20100076036 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
03/25/2010US20100076035 Transdermal Drug Delivery using an Osmolyte and Vasoactive Agent
03/25/2010US20100076034 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
03/25/2010US20100076033 Methods For Treating Hyperlipidemia with Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics
03/25/2010US20100076031 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
03/25/2010US20100076030 Methods of treating rheumatoid arthritis
03/25/2010US20100076029 Compounds Which Selectively Modulate The CB2 Receptor
03/25/2010US20100076028 Design and Synthesis of Novel Antimicrobials
03/25/2010US20100076027 Indazole or 4,5,6,7-tetrahydro-indazole derivatives
03/25/2010US20100076026 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
03/25/2010US20100076025 Process for solvent removal from omeprazole salts
03/25/2010US20100076024 Novel Compounds as Serine Protease Inhibitors
03/25/2010US20100076023 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers
03/25/2010US20100076022 Novel polymorphs of rimonabant
03/25/2010US20100076021 Organic Compounds
03/25/2010US20100076020 Quinolynylmethylimidizoles as therapeutic agents
03/25/2010US20100076019 Alcohol free formulation of argatroban
03/25/2010US20100076018 Compounds and Methods for Treatment of Alpha-1 Antitrypsin Deficiency
03/25/2010US20100076017 Sitamaquine tosylate for the treatment of leishmaniasis
03/25/2010US20100076016 Isoquinolinone derivatives as nk3 antagonists
03/25/2010US20100076015 Aminopyridine Derivatives
03/25/2010US20100076014 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100076013 Methods of Treatment
03/25/2010US20100076012 Tetrahydroquinoline derivatives and the use thereof for the treatment of cancer
03/25/2010US20100076011 Enantiomer-Pure Hexahydro-Pyrrolocyclopenta-Pyridine Derivatives
03/25/2010US20100076010 Alpha 1a-adrenoceptor antagonists
03/25/2010US20100076009 Adjuvant Chemotherapy For Anaplastic Gliomas
03/25/2010US20100076008 Pharmaceutical compositions containing plasma protein
03/25/2010US20100076007 Polymorphs of 6-Beta-Naltrexol
03/25/2010US20100076006 Topiramate Plus Naltrexone for the Treatment of Addictive Disorders
03/25/2010US20100076005 Isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities
03/25/2010US20100076004 Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/25/2010US20100076003 5-oxazolidin-2-one substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful as orl-1 receptor modulators
03/25/2010US20100076002 Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions and Pharmaceutical Compositions
03/25/2010US20100076001 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
03/25/2010US20100076000 Sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
03/25/2010US20100075999 Process for the Preparation of Ethyl-N-(2,3-Dichloro-6-Nitrobenzyl)Glycine Hydrochloride
03/25/2010US20100075998 Tricyclic indoles and (4,5-dihydro) indoles
03/25/2010US20100075997 Use of pkc inhibitors in transplantation
03/25/2010US20100075996 Pyrrolo[2,3-d]pyrimidine compounds
03/25/2010US20100075995 Compounds
03/25/2010US20100075994 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
03/25/2010US20100075993 Small molecule inhibitors against west nile virus replication
03/25/2010US20100075992 Tetrodotoxin and its derivatives for the treament of peripheral-nervously derived neuropathi pain
03/25/2010US20100075991 Post-translational regulation of catalytic activities of cytochrome P450 46A1 and uses thereof
03/25/2010US20100075990 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/25/2010US20100075989 Novel Compounds Having Selective Inhibiting Effect at GSK3
03/25/2010US20100075988 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
03/25/2010US20100075987 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075985 Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors
03/25/2010US20100075984 Dicarbonylic compounds with antibacterial activity
03/25/2010US20100075983 D3 and 5-ht2a receptor modulators
03/25/2010US20100075982 Pyridinone Derivative For The Treatment of Premature Ejaculation
03/25/2010US20100075981 such as N-{trans-4-[2-(4-Isoxazolo[4,5-c]pyridin-3-yl-piperazin-1-yl)-ethyl]-cyclohexyl}-acetamide, used for the therapeutic and/or prophylactic treatment of cognitive disorders, psychological disorders, drug abuse and drug dependence
03/25/2010US20100075980 Phenylacetamides being FLT3 Inhibitors
03/25/2010US20100075979 Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors
03/25/2010US20100075978 Sulfonamide derivatives as bradykinin antagonists
03/25/2010US20100075977 Beta-3 receptor ligands and their use in therapy
03/25/2010US20100075976 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
03/25/2010US20100075975 Medicament for the enhancement of cognitive function and neuroprotection
03/25/2010US20100075974 Heterocyclic gpr40 modulators
03/25/2010US20100075973 Polo-like kinase inhibitors
03/25/2010US20100075972 Agent for treatment of multiple sclerosis
03/25/2010US20100075971 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
03/25/2010US20100075970 Inhibitors of akt activity
1 ... 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 ... 7860